MR-guided focused ultrasound developer InSightec announced that Health Care Service (HCSC) has updated its coverage policy to include InSightec's ExAblate procedure as a treatment option for patients with bone metastases.
HCSC is the second largest Blue Cross/Blue Shield commercial insurer in the U.S.



.fFmgij6Hin.png?auto=compress%2Cformat&fit=crop&h=100&q=70&w=100)




.fFmgij6Hin.png?auto=compress%2Cformat&fit=crop&h=167&q=70&w=250)











